A recent Circana report projects a notable jump in the number of GLP-1 users in the US, reaching 35% by 2030
To see the latest GLP-1 drug shortage and supply reports, visit Ro's GLP-1 Supply Tracker: ro.co/supply-tracker About Ro Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the easiest, most effective care possible
She presented to the emergency department with severe abdominal pain, nausea, and vomiting
If this occurs, discontinue use and consult a healthcare provider
Other studies have put that range between 15 and 40 percent, depending on the protocol
de Weerd, N.A., Kurowska, A.K., Mendoza, J.L., and Schreiber, G., Structurefunction of type I and III interferons, Curr